Should military dining facilities offer and promote consumption of probiotic-containing foods?

Military Medicine

Volumn 175, Issue 10, 2010, Pages 770-783

  Smith, Tracey J ^a   Margolis, Lee M ^a   Young, Andrew J ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

CATERING SERVICE; HEALTH PROMOTION; HUMAN; REVIEW; SOLDIER; UNITED STATES;

FOOD SERVICES; HEALTH PROMOTION; HUMANS; MILITARY PERSONNEL; PROBIOTICS; UNITED STATES;

EID: 77958022791     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-10-00024     Document Type: Article

References (78)

1. Food and Agriculture Organization of the United States, World Health Organization : Guidelines for the Evaluation of Probiotics in Food: Joint FAO/WHO Working Group meeting , London Ontario, Canada , April 30-May 1, 2002. Available at ftp://ftp.fao.org/es/esn/food/wgreport2.pdf; accessed July 1, 2009.
2. Floch MH, Walker WA, Guandalini S, et al: Recommendations for probi-otic use-2008. J Clin Gastroenterol 2008; 42(Suppl 2): S104-8.
3. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, et al: Probiotic and prebi-otic influence beyond the intestinal tract. Nutr Rev 2007; 65: 469-89.
4. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6: 374-82.
5. McFarland LV: Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5: 97-105.
6. Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review . Gut 2010 ; 59 : 325-32.
7. Gascon J: Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion 2006; 73(Suppl 1): 102-8.
8. Sanders JW, Putnam SD, Frankart C, et al: Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan). Am J Trop Med Hyg 2005; 73: 713-9.
9. Riddle MS, Tribble DR, Putnam SD, et al: Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East . Am J Public Health 2008; 98: 2199-206.
10. Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
11. Thompson WG: Irritable bowel syndrome: a management strategy. Best Pract Res Clin Gastroenterol 1999; 13: 453-60.
12. Niv E, Naftali T, Hallak R, Vaisman N: The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syn-drome-a double blind, placebo-controlled, randomized study . Clin Nutr 2005; 24: 925-31.
13. Thabane M, Kottachchi DT, Marshall JK: Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 535-44.
14. Barbara G, Cremon C, Pallotti F, De GR, Stanghellini V, Corinaldesi R: Postinfectious irritable bowel syndrome . J Pediatr Gastroenterol Nutr 2009; 48(Suppl 2): S95-7.
15. Heikkinen T, Jarvinen A: The common cold. Lancet 2003; 361: 51-9.
16. Merck Manual: Respiratory Tract Infections, The Merck Manuals Online Medical Library , 2009. Available at http://www.merck.com/mmhe/sec23/ ch273/ch273i.html; accessed June 12, 2009.
17. Gwaltney JM : Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112(Suppl 6A): 13S-18S.
18. Adams P, Hendershot G, Marano M: Current estimates from the National Health Interview Survey , 1996 , Vital and Health Statistics Series 10 . Atlanta, GA , Centers for Disease Control and Prevention/National Center for Health Statistics, 1999.
19. Armed Forces Health Surveillance Center: Acute respiratory disease and streptococcal pharyngitis rates, basic combat training centers, U.S. Army, by week, February 2007-February 2009. MSMR 2009; 16: 2-8.
20. Soltis BW, Sanders JW, Putnam SD, Tribble DR, Riddle MS: Self reported incidence and morbidity of acute respiratory illness among deployed U.S. military in Iraq and Afghanistan. PLoS ONE 2009; 4: e6177.
21. de Vrese M, Winkler P, Rautenberg P, et al: Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 2006; 24: 6670-4.
22. Winkler P, de Vrese M, Laue C, Schrezenmeir J: Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters . Int J Clin Pharmacol Ther 2005; 43: 318-26.
23. Gluck U, Gebbers JO: Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003; 77: 517-20.
24. Cox AJ, Pyne DB, Saunders PU, Fricker PA: Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 2010; 44: 222-6.
25. de Vrese M, Winkler P, Rautenberg P, et al: Effect of Lactobacillus gas-seri PA 16/8, Bifi dobacterium longum SP 07/3, B. bifi dum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial . Clin Nutr 2005; 24: 481-91.
26. Kekkonen RA, Vasankari TJ, Vuorimaa T, Haahtela T, Julkunen I, Korpela R : The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners . Int J Sport Nutr Exerc Metab 2007; 17: 352-63.
27. Tiollier E, Chennaoui M, Gomez-Merino D, Drogou C, Filaire E, Guezennec CY: Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Milit Med 2007; 172: 1006-11.
28. Turchet P, Laurenzano M, Auboiron S, Antoine JM: Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003; 7: 75-7.
29. Bousquet J, Van CP, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-S334.
30. Jaber R: Respiratory and allergic diseases: from upper respiratory tract infections to asthma. Prim Care 2002; 29: 231-61.
31. Skoner DP: Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001; 108: S2-8.
32. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME: Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials . Ann Allergy Asthma Immunol 2008 ; 101:570-9.
33. Armed Forces Health Surveillance Center: Allergic rhinitis among active duty servicemembers, 1998-1999. MSMR 1999; 6: 16-18.
34. Aldinucci C, Bellussi L, Monciatti G, et al: Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients . Eur J Clin Nutr 2002; 56: 1155-61.
35. Helin T, Haahtela S, Haahtela T: No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study . Allergy 2002 ; 57: 243-6.
36. Ishida Y , Nakamura F , Kanzato H , et al : Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88: 527-33.
37. Ishida Y, Nakamura F, Kanzato H, et al: Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial . Biosci Biotechnol Biochem 2005; 69: 1652-60.
38. Tamura M, Shikina T, Morihana T, et al: Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial . Int Arch Allergy Immunol 2007 ; 143: 75-82.
39. Xiao JZ, Kondo S, Yanagisawa N, et al: Effectofprobiotic Bifi dobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial . J Investig Allergol Clin Immunol 2006; 16: 86-93.
40. Xiao JZ, Kondo S, Yanagisawa N, et al: Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial . Clin Exp Allergy 2006; 36: 1425-35.
41. Xiao JZ, Kondo S, Yanagisawa N, et al: Clinical efficacy of probiotic Bifi dobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int 2007; 56: 67-75.
42. Garcia-Godoy F, Hicks MJ: Maintaining the integrity of the enamel surface: the role of dental biofi lm, saliva and preventive agents in enamel demineralization and remineralization . J Am Dent Assoc 2008 ; 139(Suppl): 25S-34S.
43. Featherstone JD: The science and practice of caries prevention. J Am Dent Assoc 2000; 131: 887-99.
44. Caglar E, Kargul B, Tanboga I: Bacteriotherapy and probiotics' role on oral health. Oral Dis 2005; 11: 131-7.
45. Bray RM, Hourani LL, Rae KL, et al: 2005 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel , 2005. Available at http://www.ha.osd.mil/special-reports/2005-Health- Behaviors-Survey-1-07.pdf ; accessed September 1, 2009.
46. Teughels W, Van EM, Sliepen I, Quirynen M: Probiotics and oral healthcare. Periodontol 2000 2008; 48: 111-47.
47. Bratthall D, Petersen PE, Stjernswärd JR, Brown LJ: Oral and cranio-facial diseases and disorders. Disease Control Priorities in Developing Countries (2nd Edition), ed., New York : Oxford University Press ; 2006 , p. 723-36.
48. Featherstone JD: Dental caries: a dynamic disease process. Aust Dent J 2008; 53: 286-91.
49. Doron S , Gorbach SL : Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006; 4: 261-75.
50. Meurman JH, Antila H, Korhonen A, Salminen S: Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro. Eur J Oral Sci 1995; 103: 253-8.
51. Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M: Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity . Oral Microbiol Immunol 2005; 20: 354-61.
52. Strahinic I, Busarcevic M, Pavlica D, Milasin J, Golic N, Topisirovic L: Molecular and biochemical characterizations of human oral lactoba-cilli as putative probiotic candidates . Oral Microbiol Immunol 2007 ; 22: 111-7.
53. Ahola AJ, Yli-Knuuttila H, Suomalainen T, et al: Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol 2002; 47: 799-804.
54. Caglar E, Kavaloglu SC, Kuscu OO, Sandalli N, Holgerson PL, Twetman S : Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci and lactobacilli . Clin Oral Investig 2007 ; 11: 425-9.
55. Caglar E, Kuscu OO, Cildir SK, Kuvvetli SS, Sandalli N: A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli. Int J Paediatr Dent 2008; 18: 35-9.
56. Shimauchi H, Mayanagi G, Nakaya S, et al: Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study . J Clin Periodontol 2008 ; 35: 897-905.
57. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C: Short-term effect of chewing gums containing pro-biotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009; 67: 19-24.
58. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G : Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006; 30: 55-60.
59. Barrons R, Tassone D: Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review . Clin Ther 2008 ; 30: 453-68.
60. Foxman B: Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113(Suppl 1A): 5S-13S.
61. Forsum U, Holst E, Larsson PG, Vasquez A, Jakobsson T, Mattsby-Baltzer I: Bacterial vaginosis-a microbiological and immunological enigma. APMIS 2005; 113: 81-90.
62. Yen S, Shafer MA, Moncada J, Campbell CJ, Flinn SD, Boyer CB: Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military . Obstet Gynecol 2003 ; 102: 927-33.
63. Lowe NK, Ryan-Wenger NA: Military women's risk factors for and symptoms of genitourinary infections during deployment . Mil Med 2003; 168: 569-74.
64. Kontiokari T, Laitinen J, Jarvi L, Pokka T, Sundqvist K, Uhari M: Dietary factors protecting women from urinary tract infection . Am J Clin Nutr 2003; 77: 600-4.
65. Shalev E, Battino S, Weiner E, Colodner R, Keness Y: Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis . Arch Fam Med 1996; 5: 593-6.
66. Reid G, Bocking A: The potential for probiotics to prevent bacterial vagi-nosis and preterm labor. Am J Obstet Gynecol 2003; 189: 1202-8.
67. Anukam K, Osazuwa E, Ahonkhai I, et al: Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial . Microbes Infect 2006 ; 8: 1450-4.
68. Reid G, Burton J, Hammond JA, Bruce AW: Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004; 7: 223-8.
69. Reid G, Charbonneau D, Erb J, et al: Oral use of Lactobacillus rhamno-sus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women . FEMS Immunol Med Microbiol 2003; 35: 131-4.
70. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT: Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for can-didal vaginitis. Ann Intern Med 1992; 116: 353-7.
71. Pirotta M, Gunn J, Chondros P, et al: Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial . BMJ 2004; 329: 548.
72. Salminen MK, Tynkkynen S, Rautelin H, et al: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35: 1155-60.
73. Husni RN, Gordon SM, Washington JA, Longworth DL: Lactobacillus bacteremia and endocarditis: review of 45 cases . Clin Infect Dis 1997 ; 25: 1048-55.
74. Rautio M, Jousimies-Somer H, Kauma H, et al: Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999; 28: 1159-60.
75. Borriello SP, Hammes WP, Holzapfel W, et al: Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.
76. Antony SJ, Stratton CW, Dummer JS: Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis . Clin Infect Dis 1996; 23: 773-8.
77. Agheyisi R: The Probiotics Market: Ingredients, Supplements, Foods, 2008 ; FOD035B. Wellesley, MA: BCC Research.
78. Shortt C: The probiotic century: historical and cultural perspectives. Trends Food Sci Technol 1999; 10: 411-7.